November 2024

Mohammad Anas Wahaj | 25 nov 2024

India is often termed as 'Pharmacy of the World' due to its provision of low-cost generic medicines. But according to the 2024 Access to Medicine Index, published biennially by the non-profit Access to Medicine Foundation and supported by UK and Dutch governments, Indian pharma sector is seeing a slowdown in voluntary licensing and technology transfers - mechanisms essential for improving access to medicines in low- and middle-income countries (LMICs). Voluntary licensing allows pharma companies to permit other manufacturers to produce generics of patented drugs while technology transfer involves sharing the knowledge needed for local medicine production. Claudia Martinez, Director of Research at the Access to Medicine Foundation, says, 'There are some very clear opportunities for companies to scale up access and promote health equity, but more deliberate action is needed. Developing inclusive business models for low-income countries, engaging in voluntary licensing and technology transfers, and diversifying clinical trial locations are shown to be effective mechanisms for improving access. Real progress will require companies to reassess and adapt their policies to meet access equity goals.' Read on...

Business Today: India's pharma industry faces slowdown in licensing and technology transfers, says report
Author: Neetu Chandra Sharma

---

the3h | glomc00 | ilmeps | mawdesigns | anasmark | ilmeds | read | contact